Dye-guided technique to improve healing after esophageal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial is testing whether using a special dye (indocyanine green) to check blood flow during esophageal cancer surgery can help prevent leaks at the connection site. It may help make the surgery safer and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with esophageal squamous cell carcinoma by biopsy.
- Your cancer is at a stage that can be removed with surgery (stage cT1-4aN0-3M0).
- You are fit to undergo chemotherapy or immunotherapy, and surgery is not contraindicated.
- You are not allergic to indocyanine green, iodine, or contrast agents.
- You have no severe liver or kidney problems that could affect the dye used in the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a dye that helps surgeons see the first lymph nodes during esophageal cancer surgery. It might help remove fewer lymph nodes and reduce side effects.
This trial tests whether a special dye helps surgeons see and avoid the nerve that controls the voice box during minimally invasive esophageal cancer surgery. It may reduce the risk of voice problems after surgery.
This trial compares two ways to check for cancer spread in the lymph nodes during surgery for esophageal cancer. One way removes more lymph nodes, the other uses a special dye to find and remove only the ones most likely to contain cancer. The goal is to see if the dye method works just as well with fewer side effects.
This trial tests whether a special dye (indocyanine green) given through a vein can help doctors see the exact edges and depth of early-stage esophageal or stomach cancer during a minimally invasive procedure to remove it. If you are scheduled for this procedure, the dye may help the surgeon remove the cancer more precisely.
This Phase 2 study tests whether using a special light-activated dye (indocyanine green) during laparoscopic stomach surgery can improve surgical outcomes for people with remnant (leftover) stomach cancer that has not spread to distant organs. It may help surgeons better find lymph nodes while operating.
This trial tests whether a special fluorescent dye called indocyanine green (ICG) can help surgeons see better during laparoscopic Heller-Dor surgery for achalasia. It may improve the safety and success of the procedure.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.